Sign Up to like & get
recommendations!
1
Published in 2021 at "Biochemical and biophysical research communications"
DOI: 10.1016/j.bbrc.2021.09.059
Abstract: Rosiglitazone, a specific agonist of peroxisome proliferator-activated receptor-γ (PPAR-γ), displays a robust hypoglycemic action in patients with type 2 diabetes mellitus (T2DM) and elicits serious adverse reactions, especially hepatotoxicity and cardiotoxicity. Here, we aims to…
read more here.
Keywords:
lyso natural;
cardiotoxicity mice;
adverse reactions;
cardiotoxicity ... See more keywords